Stefano Buono

  • Stefano Buono
  • A graduate in Physics from Turin, after 10 years as a researcher at CERN alongside Nobel laureate Carlo Rubbia, he founded and led a pioneering biotech company in Theranostics in Nuclear Medicine, which he listed on Nasdaq in 2015 and then sold to Novartis in 2018. He invests in innovation, social causes, education, art and culture.